Company Overview and News

35
7 Consumer Stocks to Sell Now

2018-10-11 investorplace - 2
U.S. equities were under pressure again on Tuesday as investors remain fearful over rising Treasury bonds, trade tensions and the budget situation in Italy. There was some relief near the open as Italian bond yields pulled back from their highs, but buyers aren’t showing a lot of conviction here amid a lot of sector rotation rather than persistent and widespread buying.
F CPB HOG HMC WHR GT KHC GM MHK

1
MHK / Mohawk Industries, Inc. / JP Morgan Chase & Co - NONE (Passive Investment)

2018-10-05 sec.gov
Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION
MHK

1
MHK / Mohawk Industries, Inc. / JP Morgan Chase & Co - NONE (Passive Investment)

2018-10-05 sec.gov
Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION
MHK

1
In a US manufacturing hub, no illusions about tariffs and jobs

2018-09-30 thestar.com.my
Open positions: The sewing lines at Bernhard Furniture Company are growing and in need of more skilled craft workers. — Reuters
ODFL 39IB LGEPF BC94 SMSN KMTUF LGEAF LGLD ODLF MHK LGEJY LGEIY SMSD

1
In a US manufacturing hub, no illusions about tariffs and jobs

2018-09-28 channelnewsasia
THOMASVILLE, N.C.: In a town where a 30-feet tall chair is the chief landmark, and which is synonymous with a U.S. furniture industry decimated over the years by imports from China, many greet the possibility of tariffs on Chinese goods with a shrug. No wonder. Of three once bustling Thomasville furniture plants in the city limits, one is being demolished and cleared for parkland, another may become the site of a new police station, and a third is being converted into apartments.
ODFL 39IB LGEPF BC94 SMSN KMTUF LGEAF LGLD ODLF MHK LGEJY LGEIY SMSD

1
RPT-INSIGHT-In a U.S. manufacturing hub, no illusions about tariffs and jobs

2018-09-26 reuters
THOMASVILLE, N.C., Sept 26 (Reuters) - In a town where a 30-feet tall chair is the chief landmark, and which is synonymous with a U.S. furniture industry decimated over the years by imports from China, many greet the possibility of tariffs on Chinese goods with a shrug.
ODFL 39IB LGEPF BC94 SMSN KMTUF LGEAF LGLD ODLF MHK LGEJY LGEIY SMSD

1
In a U.S. manufacturing hub, no illusions about tariffs and jobs

2018-09-26 theedgemarkets
THOMASVILLE, N.C. (Sep 26): In a town where a 30-feet tall chair is the chief landmark, and which is synonymous with a U.S. furniture industry decimated over the years by imports from China, many greet the possibility of tariffs on Chinese goods with a shrug.
ODFL 39IB LGEPF BC94 SMSN KMTUF LGEAF LGLD ODLF MHK LGEJY LGEIY SMSD

1
INSIGHT-In a U.S. manufacturing hub, no illusions about tariffs and jobs

2018-09-26 reuters
THOMASVILLE, N.C. (Reuters) - In a town where a 30-feet tall chair is the chief landmark, and which is synonymous with a U.S. furniture industry decimated over the years by imports from China, many greet the possibility of tariffs on Chinese goods with a shrug.
ODFL 39IB LGEPF BC94 SMSN KMTUF LGEAF LGLD ODLF MHK LGEJY LGEIY SMSD

2
Mohawk's (MHK) Downtrend Continues: What's Hurting the Stock?

2018-09-25 zacks - 1
Despite undertaking several strategic measures to drive performance, Mohawk Industries, Inc. (MHK - Free Report) failed to impress investors. The company’s shares have declined 26% in a year’s time compared with the industry’s decline of 20.7%. Let’s delve deeper and try to assess what’s taking this Zacks Rank #5 (Strong Sell) company down the hill. Rising Costs Hurt Profit Margins Mohawk is bearing the brunt of higher raw materials, labor, energy and fuel-related costs, which impacted its profitability.
CRI MHK GLUU CAL

3
Textile-Home Furnishing Industry Outlook: Prospects Bleak

2018-09-25 zacks
The Textile-Home Furnishing industry — comprising manufacturers, designers, distributors and marketers of flooring, carpet and upholstery products — seems to be going through a rough patch. Rising raw material costs, higher transportation costs, a stronger dollar and a tight labor market have been creating hurdles for the industry players. Nevertheless, the companies are registering higher demand courtesy of improving consumer confidence, a lower unemployment rate and higher disposable income.
DXYN CULP MHK TILE

1
A 'Shout Out' To Mohawk Industries

2018-09-05 seekingalpha
The stock of Mohawk Industries has had rough go of it recently as the company is dealing with cost inflation in many of its key inputs.
MHK

101
Tracking Stephen Mandel's Lone Pine Capital Portfolio - Q2 2018 Update

2018-09-04 seekingalpha - 2
Stephen Mandel’s 13F portfolio value decreased ~4% from $19.74B to $18.91B. The number of positions decreased from 30 to 28.
STZ.B FB CP SQNXF NOW PYPL GOOG NVDA ADBE ATVI DLTR CP AMZN AVGO CSX MELI TSM IQV EA SQ WYNN TDG TRU TMUSP TMUS STZ EXAS SE BABA BLK BKNG GOOGL MSFT BRCM MHK UNH SBAC

94
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2018 Update

2018-09-03 seekingalpha - 1
Glenview Capital Management's 13F portfolio value decreased from $17.10B to $14.66B this quarter. The number of positions decreased from 52 to 49.
LOW ATHTF FLEX LBTY WBA ENL CVS HPE SHPG NWL LBTYK LILAB WMB DOW MTOR CAH DXC AET CMCSK IQV EBAY MIK TMUSP TMUS BKD CBS.WD VER CNDT GOOGL LILAK RLGY MSFT CPV MHK ENDP FB PAH TMO CCV MCK CCZ GOOG DLPH CHTR AGN DXC.WI CI ARMK HOLX CBS CSC CBS.A CMCSA FTI.WI FMC LBTYB LBTYA FDX ANTM HUM DWDP ABC V CCV.CL FDC THC APTV ANTX LILA

1
Mohawk Industries Inc. 2018 Q2 - Results - Earnings Call Slides

2018-08-20 seekingalpha
The following slide deck was published by Mohawk Industries Inc. in conjunction with their 2018 Q2 earnings call.
MHK

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to MHK / Mohawk Industries, Inc. on message board site Silicon Investor.

MHK - Mohawk MHK - Mohawk MHK - Mohawk Mohawk, MHK a Consumer Cyclical star Mohawk, MHK a Consumer Cyclical star Mohawk, MHK a Consumer Cyclical star
Mohawk canada Mohawk canada Mohawk canada
CUSIP: 608190104